![conference banner](/images/conference-banner.jpeg)
Abstract
Background: Epigallocatechin-3-gallate (EGCG) is an important pharmacological component in tea, and various effects, including anti-tumor, anti-inflammation, anti-aging, antiobesity, anti-diabetes, cardiovascular disease prevention and protection, immunoregulation, and neuroprotection, of this component have been confirmed. However, EGCG has been rarely used in clinical applications because of its poor stability and low bioavailability.
Objective: The work summarizes the characteristics about EGCG, describes its pharmacological mechanisms, explores the clinical availability of EGCG, and establishes a basis for EGCG preparations in clinical applications.
Conclusion: In addition to altering dosage forms or synthesizing analogs to overcome losses during absorption, inducing gauxiliary effect and enhancing chemosensitivity can be achieved by EGCG in a combined medication. The pharmacological action, pharmacology network, including mutation of signaling receptor and modulation of intracellular signaling pathway, and combination treatment strategy of EGCG are clarified and distinguished. Possible targets and combined applications based on the characteristics of EGCG are also systematically summarized. EGCG may be a candidate compound that maintains balance of the patient's disease progression and becomes suitable for clinical use in combination treatment.
Keywords: EGCG, auxiliary effect, enhancing chemosensitivity, combined medication, pharmacological action, pharmacology network.
Combinatorial Chemistry & High Throughput Screening
Title:Epigallocatechin-3-gallate(EGCG): Mechanisms and the Combined Applications
Volume: 20 Issue: 10
Author(s): Xuekun Song, Juan Du, Wenyuan Zhao and Zheng Guo*
Affiliation:
- College of Bioinformatics Science and Technology, Harbin Medical University, Harbin,China
Keywords: EGCG, auxiliary effect, enhancing chemosensitivity, combined medication, pharmacological action, pharmacology network.
Abstract: Background: Epigallocatechin-3-gallate (EGCG) is an important pharmacological component in tea, and various effects, including anti-tumor, anti-inflammation, anti-aging, antiobesity, anti-diabetes, cardiovascular disease prevention and protection, immunoregulation, and neuroprotection, of this component have been confirmed. However, EGCG has been rarely used in clinical applications because of its poor stability and low bioavailability.
Objective: The work summarizes the characteristics about EGCG, describes its pharmacological mechanisms, explores the clinical availability of EGCG, and establishes a basis for EGCG preparations in clinical applications.
Conclusion: In addition to altering dosage forms or synthesizing analogs to overcome losses during absorption, inducing gauxiliary effect and enhancing chemosensitivity can be achieved by EGCG in a combined medication. The pharmacological action, pharmacology network, including mutation of signaling receptor and modulation of intracellular signaling pathway, and combination treatment strategy of EGCG are clarified and distinguished. Possible targets and combined applications based on the characteristics of EGCG are also systematically summarized. EGCG may be a candidate compound that maintains balance of the patient's disease progression and becomes suitable for clinical use in combination treatment.
Export Options
About this article
Cite this article as:
Song Xuekun , Du Juan , Zhao Wenyuan and Guo Zheng *, Epigallocatechin-3-gallate(EGCG): Mechanisms and the Combined Applications, Combinatorial Chemistry & High Throughput Screening 2017; 20 (10) . https://dx.doi.org/10.2174/1386207321666171218115850
DOI https://dx.doi.org/10.2174/1386207321666171218115850 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
Call for Papers in Thematic Issues
Artificial Intelligence Methods for Biomedical, Biochemical and Bioinformatics Problems
Recently, a large number of technologies based on artificial intelligence have been developed and applied to solve a diverse range of problems in the areas of biomedical, biochemical and bioinformatics problems. By utilizing powerful computing resources and massive amounts of data, methods based on artificial intelligence can significantly improve the ...read more
Exploring Spectral Graph Theory in Combinatorial Chemistry
Combinatorial chemistry involves the synthesis and analysis of a large number of diverse compounds simultaneously. Traditional methods rely on brute-force experimentation, which can be time-consuming and resource-intensive. Spectral graph theory, a branch of mathematics dealing with the properties of graphs in relation to the eigenvalues and eigenvectors of matrices associated ...read more
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Advances In Developing Novel Anti-Cancer Drugs Targeting Tumor Hypoxic and Acidic Microenvironments
Recent Patents on Anti-Cancer Drug Discovery Advances in Regulating Tumorigenicity and Metastasis of Cancer Through TrkB Signaling
Current Cancer Drug Targets Current Concepts of Pain Pathways: A Brief Review of Anatomy, Physiology, and Medical Imaging
Current Medical Imaging Zerumbone Sensitizes the Anti-Cancer Efficacy of Cisplatin in Hepatocellular Carcinoma Cells
Anti-Cancer Agents in Medicinal Chemistry Exploring the Therapeutic Potential of Chalcones in Oncology: A Comprehensive Review
Current Bioactive Compounds Shear-Wave and Strain Elastography: A Comparative Review on Principles, Basic Techniques and Applications.
Current Medical Imaging Identification of Critical MicroRNA Gene Targets in Cervical Cancer Using Network Properties
MicroRNA E6 and E7 Oncoproteins: Potential Targets of Cervical Cancer
Current Medicinal Chemistry Epigenetic Regulation of Genes Encoding Drug-Metabolizing Enzymes and Transporters; DNA Methylation and Other Mechanisms
Current Drug Metabolism Selective VEGFR Inhibitors for Anticancer Therapeutics in Clinical Use and Clinical Trials
Current Pharmaceutical Design LPA and its Analogs-Attractive Tools for Elucidation of LPA Biology and Drug Development
Current Medicinal Chemistry Current Genome Editing Tools in Gene Therapy: New Approaches to Treat Cancer
Current Gene Therapy Cu-mediated synthesis of 2,3-dihydro-1H-pyrrolo[3,2,1-ij]quinolin-1-ones as potential inhibitors of sirtuins
Letters in Drug Design & Discovery The Genus Glycosmis [Rutaceae]: A Comprehensive Review on its Phytochemical and Pharmacological Perspectives
The Natural Products Journal PDE5 Inhibitor Treatment Options for Urologic and Non-Urologic Indications: 2012 Update
Current Pharmaceutical Design Evaluation of Paclitaxel Effects in The Pattern of Expression of Survival and Apoptotic Genes Regulators in HeLa Cells
Current Pharmaceutical Biotechnology Disulfiram, and Disulfiram Derivatives as Novel Potential Anticancer Drugs Targeting the Ubiquitin Proteasome System in Both Preclinical and Clinical Studies
Current Cancer Drug Targets Gene Therapy for the Peripheral Nervous System: A Strategy to Repair the Injured Nerve?
Current Gene Therapy Bisphosphonates: Molecular Mechanisms of Action and Effects on Bone Cells, Monocytes and Macrophages
Current Pharmaceutical Design Radioactive Nanoparticles and their Main Applications: Recent Advances
Recent Patents on Nanotechnology